Medical Director/Global Medical Indication Lead - Nephrology(FSP)
Thermo Fisher ScientificSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, BiotechnologyIndustries
Requirements
Candidates must hold an M.D. or D.O. degree with board certification in Oncology, and possess at least five years of experience in oncology, preferably including clinical research and development. Strong knowledge in GU (particularly bladder and kidney) cancers, along with experience in clinical trials, is preferred.
Responsibilities
The Medical Director, GU Oncology will collaborate with cross-functional teams to develop clinical strategies for Natera’s oncology products, focusing on GU cancers. They will oversee medical education and communication for healthcare providers, represent Natera at medical conferences, and collaborate with research and development teams on clinical trial design and data analysis. Furthermore, they will provide expert guidance on GU oncology cases and clinical trials, ensuring the scientific integrity and clinical adoption of Natera’s oncology testing solutions.
Skills
GU cancers
bladder cancer
kidney cancer
clinical development
medical education
scientific communication
clinical trial design
data analysis
oncology expertise
medical advocacy
Natera
Genetic testing and diagnostics solutions provider
About Natera
Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.
Key Metrics
Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees